The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Enzalutamide

Australian Public Assessment Report

AusPAR

AusPAR: Enzalutamide [PDF, 1.03 MB]

AusPAR: Enzalutamide [Word, 1.68 MB]

Attachment: Product Information: Enzalutamide [PDF, 315.73 KB]

Attachment: Product Information: Enzalutamide [Word, 359.22 KB]

Attachment: Extract from the Clinical Evaluation Report: Enzalutamide [PDF, 1.01 MB]

Attachment: Extract from the Clinical Evaluation Report: Enzalutamide [Word, 1.95 MB]

Device/Product Name

Xtandi

Active ingredients

Enzalutamide

AusPAR Date

24 November 2014

Published

14 January 2015

Submission Number

PM-2013-01155-1-4

Submission Type

New chemical entity

Decision

Approved